Hospital Medicine News

Pfizer announced Wednesday that it has initiated a phase 2/3 study of its COVID-19 antiviral for pediatric patients.

Upamostat reduced hospitalizations for COVID-19 by 100% and significantly reduced the development of new, severe symptoms when administered early to symptomatic patients, according to a press release from the manufacturer.

The leading U.S. professional association for infection preventionists published recommendations on Tuesday that it said will ensure the country is better prepared to protect patients during a health emergency like COVID-19.

Common drugs like paracetamol and ibuprofen may reduce a patient’s immune response if taken before or immediately following a vaccination, according to findings published in the British Journal of Clinical Pharmacology.

Researchers found a significant association between neighborhood socioeconomic depression and missed clinic visits for children with medical complexity, according to a study published in Pediatrics.

Six Boston area hospitals will recruit more than 900 participants for a multiyear study of the effects of long COVID.

The COVID-19 pandemic disrupted progress toward gender equity in medicine that may resonate for years to come, according to experts.

On the heels of President Joe Biden’s State of the Union address, his administration announced a new National COVID-19 Preparedness Plan, which includes a test-to-treat initiative.

Russia’s invasion of Ukraine is hindering humanitarian access and disrupting medical supply chains that are critical to health care in the besieged country, according to WHO.

Real-world evidence published Tuesday in MMWR demonstrated that the Pfizer-BioNTech vaccine has protected children and adolescents against COVID-19, including kids aged 5 to 11 years.